Dr Martens PLC
LSE:DOCS

Watchlist Manager
Dr Martens PLC Logo
Dr Martens PLC
LSE:DOCS
Watchlist
Price: 56.4 GBX 4.25% Market Closed
Market Cap: 542.5m GBX
Have any thoughts about
Dr Martens PLC?
Write Note

Intrinsic Value

The intrinsic value of one DOCS stock under the Base Case scenario is 136.95 GBX. Compared to the current market price of 56.4 GBX, Dr Martens PLC is Undervalued by 59%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DOCS Intrinsic Value
136.95 GBX
Undervaluation 59%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Dr Martens PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for DOCS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about DOCS?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Dr Martens PLC

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Dr Martens PLC

Provide an overview of the primary business activities
of Dr Martens PLC.

What unique competitive advantages
does Dr Martens PLC hold over its rivals?

What risks and challenges
does Dr Martens PLC face in the near future?

Has there been any significant insider trading activity
in Dr Martens PLC recently?

Summarize the latest earnings call
of Dr Martens PLC.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Dr Martens PLC.

Provide P/S
for Dr Martens PLC.

Provide P/E
for Dr Martens PLC.

Provide P/OCF
for Dr Martens PLC.

Provide P/FCFE
for Dr Martens PLC.

Provide P/B
for Dr Martens PLC.

Provide EV/S
for Dr Martens PLC.

Provide EV/GP
for Dr Martens PLC.

Provide EV/EBITDA
for Dr Martens PLC.

Provide EV/EBIT
for Dr Martens PLC.

Provide EV/OCF
for Dr Martens PLC.

Provide EV/FCFF
for Dr Martens PLC.

Provide EV/IC
for Dr Martens PLC.

Show me price targets
for Dr Martens PLC made by professional analysts.

What are the Revenue projections
for Dr Martens PLC?

How accurate were the past Revenue estimates
for Dr Martens PLC?

What are the Net Income projections
for Dr Martens PLC?

How accurate were the past Net Income estimates
for Dr Martens PLC?

What are the EPS projections
for Dr Martens PLC?

How accurate were the past EPS estimates
for Dr Martens PLC?

What are the EBIT projections
for Dr Martens PLC?

How accurate were the past EBIT estimates
for Dr Martens PLC?

Compare the revenue forecasts
for Dr Martens PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Dr Martens PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Dr Martens PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Dr Martens PLC compared to its peers.

Compare the P/E ratios
of Dr Martens PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Dr Martens PLC with its peers.

Analyze the financial leverage
of Dr Martens PLC compared to its main competitors.

Show all profitability ratios
for Dr Martens PLC.

Provide ROE
for Dr Martens PLC.

Provide ROA
for Dr Martens PLC.

Provide ROIC
for Dr Martens PLC.

Provide ROCE
for Dr Martens PLC.

Provide Gross Margin
for Dr Martens PLC.

Provide Operating Margin
for Dr Martens PLC.

Provide Net Margin
for Dr Martens PLC.

Provide FCF Margin
for Dr Martens PLC.

Show all solvency ratios
for Dr Martens PLC.

Provide D/E Ratio
for Dr Martens PLC.

Provide D/A Ratio
for Dr Martens PLC.

Provide Interest Coverage Ratio
for Dr Martens PLC.

Provide Altman Z-Score Ratio
for Dr Martens PLC.

Provide Quick Ratio
for Dr Martens PLC.

Provide Current Ratio
for Dr Martens PLC.

Provide Cash Ratio
for Dr Martens PLC.

What is the historical Revenue growth
over the last 5 years for Dr Martens PLC?

What is the historical Net Income growth
over the last 5 years for Dr Martens PLC?

What is the current Free Cash Flow
of Dr Martens PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Dr Martens PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Dr Martens PLC

Current Assets 437.2m
Cash & Short-Term Investments 111.1m
Receivables 70m
Other Current Assets 256.1m
Non-Current Assets 515.2m
Long-Term Investments 1m
PP&E 232.9m
Intangibles 270m
Other Non-Current Assets 11.3m
Current Liabilities 153.5m
Accounts Payable 92.2m
Accrued Liabilities 8.4m
Other Current Liabilities 52.9m
Non-Current Liabilities 430.7m
Long-Term Debt 421.6m
Other Non-Current Liabilities 9.1m
Efficiency

Earnings Waterfall
Dr Martens PLC

Revenue
877.1m GBP
Cost of Revenue
-301.9m GBP
Gross Profit
575.2m GBP
Operating Expenses
-448.8m GBP
Operating Income
126.4m GBP
Other Expenses
-57.2m GBP
Net Income
69.2m GBP

Free Cash Flow Analysis
Dr Martens PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

DOCS Profitability Score
Profitability Due Diligence

Dr Martens PLC's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Positive 3-Year Average ROIC
Positive Free Cash Flow
62/100
Profitability
Score

Dr Martens PLC's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

DOCS Solvency Score
Solvency Due Diligence

Dr Martens PLC's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Average Altman Z-Score
Long-Term Solvency
Average D/E
47/100
Solvency
Score

Dr Martens PLC's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DOCS Price Targets Summary
Dr Martens PLC

Wall Street analysts forecast DOCS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DOCS is 77.01 GBX with a low forecast of 60.6 GBX and a high forecast of 99.75 GBX.

Lowest
Price Target
60.6 GBX
7% Upside
Average
Price Target
77.01 GBX
37% Upside
Highest
Price Target
99.75 GBX
77% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for DOCS?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for DOCS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

DOCS Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

DOCS News

Profile

Dr Martens PLC Logo
Dr Martens PLC

Country

United Kingdom

Industry

Textiles, Apparel & Luxury Goods

Market Cap

542.3m GBP

Dividend Yield

4.52%

Description

Dr. Martens Plc engages in the manufacture and sale of footwear products. The firm operates through three reporting segments: Europe, the Middle East and Africa (EMEA), Americas and Americas and Asia-Pacific (APAC). Its product categories include Originals, Fusion, Kids, Casual and Accessories. The Originals category comprises boots, shoes and loafers and also included within the Originals category is the Made in England range. The Fusion category comprises platform boots and shoes, sandals, heels and refined take downs of the Originals. Within the Kids category is the mini-me range, which includes Originals, Fusion and Casual collections. The company offers various accessories, such as shoe care, laces and socks, leather bags and small leather items. The company operates in over 60 countries globally, through a range of modes: directly operated stores and ecommerce sites, wholesale partners and distributors.

Contact

London
28 Jamestown Rd, Camden
+443713842030.0
www.drmartensplc.com

IPO

2021-01-29

Employees

1 897

Officers

CEO & Director
Mr. Kenneth Wilson
Chief Brand Officer
Mr. Onyeije Ogueri Nwokorie
CFO & Director
Mr. Giles Wilson
Chief Operating Officer
Mr. Geert Peeters
Chief Technology Officer
Graham Calder
Chief People Officer
Ms. Bridget Jolliffe
Show More
Chief Sustainability Officer
Ms. Emily Clare Reichwald
Chief Digital Officer
Mr. Sean O'Neill
President of APAC
Mr. Derek Chan
Chief Product Officer
Mr. Adam M. Meek
Show Less

See Also

Discover More
What is the Intrinsic Value of one DOCS stock?

The intrinsic value of one DOCS stock under the Base Case scenario is 136.95 GBX.

Is DOCS stock undervalued or overvalued?

Compared to the current market price of 56.4 GBX, Dr Martens PLC is Undervalued by 59%.

Back to Top